CompletedNCT04987476

Rhabdoid Tumors Cellular Architecture by Single-cell Analyses (InnovRT-2)

Studying Atypical teratoid rhabdoid tumor

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Assistance Publique - Hôpitaux de Paris
Principal Investigator
Kevin Beccaria, MD, PhD, Pr, M.D
APHP Assistance Publique des Hôpitaux de Paris
Intervention
analyzes in singles cells(biological)
Enrollment
15 enrolled
Eligibility
17 years · All sexes
Timeline
2022 – 2025

Study locations (1)

Collaborators

Institut Curie · URC-CIC Paris Descartes Necker Cochin

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04987476 on ClinicalTrials.gov

Other trials for Atypical teratoid rhabdoid tumor

Additional recruiting or active studies for the same condition.

See all trials for Atypical teratoid rhabdoid tumor →

← Back to all trials